PTCT · Company research
PTC Therapeutics, Inc. (PTCT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics (NASDAQ:PTCT) Stock Rating Raised to "Strong-Buy" at UBS Group - MarketBeat | PTC Therapeutics (NASDAQ:PTCT) Stock Rating Raised to "Strong-Buy" at UBS Group MarketBeat | View source ↗ | MarketBeat | Oct 17, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (NASDAQ:PTCT) Director Michael Schmertzler Sells 2,500 Shares of Company Stock - MarketBeat | PTC Therapeutics (NASDAQ:PTCT) Director Michael Schmertzler Sells 2,500 Shares of Company Stock MarketBeat | View source ↗ | MarketBeat | Oct 16, 2026 | neutral | 0 | 0.6 |
| Planned sales of 2,118 and 382 PTC Therapeutics (PTCT) shares came from Section Six Partners. - Stock Titan | Planned sales of 2,118 and 382 PTC Therapeutics (PTCT) shares came from Section Six Partners. Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote & History - Yahoo! Finance Canada | PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Truist Resumes Coverage on PTC Therapeutics (PTCT) with Hold, Ci - GuruFocus | Truist Resumes Coverage on PTC Therapeutics (PTCT) with Hold, Ci GuruFocus | View source ↗ | GuruFocus | Oct 16, 2026 | neutral | 0 | 0.6 |
| A rare-disease drugmaker's Oct. 29 webcast includes a business update; replay stays online for 30 days. - Stock Titan | A rare-disease drugmaker's Oct. 29 webcast includes a business update; replay stays online for 30 days. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (PTCT) Stock Looks About Right At This Price - Simply Wall Street | PTC Therapeutics (PTCT) Stock Looks About Right At This Price Simply Wall Street | View source ↗ | Simply Wall Street | Oct 15, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics, Inc. (PTCT) Stock Forecasts - Yahoo Finance | PTC Therapeutics, Inc. (PTCT) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 192 Shares of Company Stock - MarketBeat | PTC Therapeutics (NASDAQ:PTCT) VP Mark Elliott Boulding Sells 192 Shares of Company Stock MarketBeat | View source ↗ | MarketBeat | Oct 13, 2026 | neutral | 0 | 0.6 |
| After exercising options at $39.42, PTC Therapeutics (PTCT) CLO Boulding sells 192 shares. - Stock Titan | After exercising options at $39.42, PTC Therapeutics (PTCT) CLO Boulding sells 192 shares. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics, Inc. (PTCT) Stock Forecasts - Yahoo Finance | PTC Therapeutics, Inc. (PTCT) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 13, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics, Inc. (PTCT) Stock Forecasts - Yahoo Finance | PTC Therapeutics, Inc. (PTCT) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 12, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock Has Consensus Target Price of $98.25 According to Brokerages - MarketBeat | PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock Has Consensus Target Price of $98.25 According to Brokerages MarketBeat | View source ↗ | MarketBeat | Oct 10, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (NASDAQ:PTCT) Stock Gets Downgrade from Wall Street Zen - MarketBeat | PTC Therapeutics (NASDAQ:PTCT) Stock Gets Downgrade from Wall Street Zen MarketBeat | View source ↗ | MarketBeat | Oct 10, 2026 | neutral | 0 | 0.6 |
| Under a trading plan, Section Six sells 2,500 PTC Therapeutics (PTCT) shares. - Stock Titan | Under a trading plan, Section Six sells 2,500 PTC Therapeutics (PTCT) shares. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Officer Mark Elliott Boulding proposes selling 192 shares of PTC Therapeutics (Nasdaq: PTCT). - Stock Titan | Officer Mark Elliott Boulding proposes selling 192 shares of PTC Therapeutics (Nasdaq: PTCT). Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| Stock Market Today, Oct. 5: Tech Momentum Lifts Nasdaq as Treasury Yields Surge | The Nasdaq gained 1.05% to 27,477 as tech optimism drove market gains despite rising Treasury yields. The S&P 500 rose 0.66% and the Dow added 0.18%. Key movers included Vaxcyte (up 30% on vaccine success), Genmab (up 11% on lymphoma drug data), and PTC (following a $22.6B buyout offer). Nvidia gained 2.12% amid speculation about reaching a $6 trillion market cap. Investors showed increased appetite for risk following softer-than-expected jobs data, reducing expectations for further Fed rate hikes. | View source ↗ | The Motley Fool | Oct 5, 2026 | bullish | 1 | 1 |
| PTCT Stock Price, Quote & Chart - ChartMill | PTCT Stock Price, Quote & Chart ChartMill | View source ↗ | ChartMill | Oct 2, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (PTCT) Stock Looks Expensive As Its 175% Run Draws Focus - Simply Wall Street | PTC Therapeutics (PTCT) Stock Looks Expensive As Its 175% Run Draws Focus Simply Wall Street | View source ↗ | Simply Wall Street | Sep 25, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (PTCT) Stock Drops As Profit Surge Meets Launch Concentration Risk - Simply Wall Street | PTC Therapeutics (PTCT) Stock Drops As Profit Surge Meets Launch Concentration Risk Simply Wall Street | View source ↗ | Simply Wall Street | Jul 31, 2026 | neutral | 0 | 0.6 |
| PTC Therapeutics (PTCT) Stock May Be Fully Priced After Rare Disease Data - Yahoo Finance | PTC Therapeutics (PTCT) Stock May Be Fully Priced After Rare Disease Data Yahoo Finance | View source ↗ | Yahoo Finance | Jul 11, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.